Skip to main content

ADVERTISEMENT

colorectal cancer

Interview
03/03/2015
Guest blog post for Interventional Oncology 360 by Ryan M. Hickey, MD, interventional radiologist and assistant professor in radiology at Northwestern University, Chicago, ILIn the United States, colorectal cancer is the third most common...
Guest blog post for Interventional Oncology 360 by Ryan M. Hickey, MD, interventional radiologist and assistant professor in radiology at Northwestern University, Chicago, ILIn the United States, colorectal cancer is the third most common...
Guest blog post for...
03/03/2015
IO Learning
News
01/31/2015
SYDNEY, Jan. 30, 2015 /PRNewswire/ -- Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line SIR-Spheres® Y-90 resin microspheres treatment to a...
SYDNEY, Jan. 30, 2015 /PRNewswire/ -- Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line SIR-Spheres® Y-90 resin microspheres treatment to a...
SYDNEY, Jan. 30,...
01/31/2015
IO Learning
Clinical Insights
06/23/2014

By Jesus Esquivel, MD, FACS

By Jesus Esquivel, MD, FACS
Abstract: Introduction: The appropriate sequence and timing of currently available therapies for patients with peritoneal carcinomatosis of gastrointestinal origin continue to be debated among medical and surgical oncologists. Material and...
Abstract: Introduction: The appropriate sequence and timing of currently available therapies for patients with peritoneal carcinomatosis of gastrointestinal origin continue to be debated among medical and surgical oncologists. Material and...
Abstract: Introduction: The...
06/23/2014
IO Learning
News
01/22/2014
Durham, NC – A new study published online today in The Oncologist journal shows that an assessment of metabolic response in patients with metastatic colon cancer (mCC) treated with a single course of chemotherapy could predict the downstream...
Durham, NC – A new study published online today in The Oncologist journal shows that an assessment of metabolic response in patients with metastatic colon cancer (mCC) treated with a single course of chemotherapy could predict the downstream...
Durham, NC – A new study...
01/22/2014
IO Learning